Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Accounts Payables (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Accounts Payables for 16 consecutive years, with $976411.0 as the latest value for Q3 2025.

  • On a quarterly basis, Accounts Payables fell 54.54% to $976411.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $976411.0, a 54.54% decrease, with the full-year FY2024 number at $1.8 million, down 34.01% from a year prior.
  • Accounts Payables was $976411.0 for Q3 2025 at GeoVax Labs, down from $1.8 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.2 million in Q3 2023 to a low of $232482.0 in Q1 2021.
  • A 5-year average of $1.6 million and a median of $1.7 million in 2022 define the central range for Accounts Payables.
  • Biggest YoY gain for Accounts Payables was 668.59% in 2021; the steepest drop was 68.62% in 2021.
  • GeoVax Labs' Accounts Payables stood at $2.1 million in 2021, then dropped by 15.06% to $1.7 million in 2022, then soared by 60.38% to $2.8 million in 2023, then tumbled by 34.01% to $1.8 million in 2024, then tumbled by 47.21% to $976411.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Accounts Payables are $976411.0 (Q3 2025), $1.8 million (Q2 2025), and $2.4 million (Q1 2025).